OTC Healthcare - France
OTC Healthcare in France : Market Insight
EXECUTIVE SUMMARY
Slow Growth De-reimbursement Limited Impact Pharmacies Stronghold Lessening Changing Mentalities Potential Growth KEY TRENDS AND DEVELOPMENTS
OTC Products in Difficult Trading Conditions Demographic Trends Impact Demand De-reimbursement: Does it Work? Economic Growth Increases Visits to Private Doctors Hectic Lifestyles and Rising Health Awareness Drive Sales MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Advertising Packaging and Labelling Distribution De-listing or De-reimbursement Vitamins and Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - France
Arkopharma SA, Laboratoires Pharmaceutiques - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 2 Arkopharma SA, Laboratoires Pharmaceutiques: Key Facts
Summary 3 Arkopharma SA, Laboratoires Pharmaceutiques: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Arkopharma SA, Laboratoires Pharmaceutiques: Competitive Position 2006
Beaufour-Ipsen SA - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 5 Beaufour-Ipsen SA: Key Facts
Summary 6 Beaufour-Ipsen SA: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 7 Beaufour-Ipsen SA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Beaufour-Ipsen SA: Competitive Position 2006
Juva Sant, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 9 Juva Sant, Laboratoires: Key Facts
Summary 10 Juva Sant, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 11 Juva Sant, Laboratoires: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 12 Juva Sant, Laboratoires: Competitive Position 2006
Laboratoires Martin-Johnson & Johnson-MSD SAS - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 13 Laboratoires Martin-Johnson & Johnson-MSD SAS: Key Facts
Summary 14 Laboratoires Martin-Johnson & Johnson-MSD SAS: Operational Indicators 2004-2006
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 15 Laboratoires Martin-Johnson & Johnson-MSD SAS: Competitive Position 2006
Pfizer Sant Grand Public - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 16 Pfizer Sant Grand Public: Key Facts
Summary 17 Pfizer Sant Grand Public: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 18 Pfizer Sant Grand Public: Competitive Position 2006
Pierre Fabre SA, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 19 Pierre Fabre SA, Laboratoires: Key Facts
Summary 20 Pierre Fabre SA, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION
Summary 21 Pierre Fabre SA, Laboratoires: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 22 Pierre Fabre SA, Laboratoires: Competitive Position 2006
Thraplix SA - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 23 Thraplix SA: Key Facts
Summary 24 Thraplix SA: Operational Indicators 2004-2006
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 25 Thraplix SA: Competitive Position 2006
UPSA, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 26 UPSA Conseil SAS: Key Facts
Summary 27 UPSA Conseil SAS: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 28 UPSA, Laboratoires: Competitive Position 2006
Urgo, Laboratoires - OTC Healthcare - France
STRATEGIC DIRECTION KEY FACTS
Summary 29 Urgo, Laboratoires: Key Facts
Summary 30 Urgo, Laboratoires: Operational Indicators 2004-2006
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 31 Urgo, Laboratoires: Competitive Position 2006
Analgesics in France
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2001-2006
Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 14 Herbal vs Standard Topical Analgesics 2001/2006
Table 15 Analgesics Company Shares by Retail Value 2002-2006
Table 16 Analgesics Brand Shares by Retail Value 2003-2006
Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
